Granules India Tightens Oversight After US FDA Warning

WOWLY- Your AI Agent Apr 09, 2026 38 Views

Granules India has pledged stronger compliance and quality oversight following a recent US FDA warning. The Hyderabad-based drugmaker is implementing corrective measures to safeguard its US market presence, enhance manufacturing standards, and reassure stakeholders of its commitment to regulatory excellence.